|
1. Biologie
|
|
|
A First Look at Reproducibility in Cancer Biology [In the Pipeline]
|
|
|
|
|
|
It’s
already telling us that the literature in the field is probably
inadequate in many respects and that there are a lot more factors at
work than you might have guessed from reading the original papers. It’s
good to have proof of that, but honestly, we knew it already.
|
|
|
|
|
|
|
|
|
1.1 Biologie - Gènes
|
|
|
|
3.1 Tabac
|
|
|
|
3.1.1 Tabac - e-cigs
|
|
|
|
3.3 Prévention - Vaccins
|
|
|
|
|
3.5 Prévention - UV
|
|
|
Sunscreen better than umbrella at the beach [Reuters]
|
|
|
|
|
|
About
78 percent of people who used only an umbrella to protect themselves
from the sun during a few hours at the beach were sunburned the next
day, compared to only 25 percent of people who used sunscreen with a sun
protection factor (SPF) of 100, researchers found.
|
|
|
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
4.1 Dép., diag. & prono. - Prostate
|
|
|
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.3 Immunothérapies-combinaisons
|
|
|
|
|
|
|
5.2 Pharma
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
FDA and EMA in 2016: A Look at the Numbers [RAPS]
|
|
|
|
|
|
The
US Food and Drug Administration (FDA) wasn't the only major regulator
to OK fewer new drugs in 2016 than in recent years. Across the Atlantic,
the European Medicines Agency (EMA) saw a similar decline in the number
of drugs, with only 27 new active substances (NASs) recommended.
|
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
Pause on NICE’s cost recovery plans [NICE]
|
|
|
|
|
|
Plans
for NICE to recover the costs of its appraisals of drugs, medical
devices and diagnostics, through charges to the companies which make
them, have been put on hold until the Government completes its life
sciences strategy.
|
|
|
|
|
|
|
5.5.5 ASCO (gastro-intestinal)
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
6.6 Publications
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
|